Analysts expect over 2017 rising revenue DSM

Tomorrow the Dutch company DSM will publish her past quarter's results. For this year DSM 's revenue will be around 8,39 billion euros. This is according to the average of the analysts' estimates. This is slightly more than 2016's revenue of 7,92 billion euros.

Historical revenues and results DSM plus estimates 2017

financial analysis

The analysts expect for 2017 a net profit of 640 million euros. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 3,71 euros. With this the price/earnings-ratio is 16,71.

Per share the analysts expect a dividend of 1,82 euros per share. The dividend yield is then 2,94 percent. The average dividend yield of the chemical companies equals a poor 0,94 percent.

Recent target prices around 76 euros

The latest 3 recommendations for the chemical company were provided by Barclays , Jefferies & Co. and UBS .

Based on the current number of shares DSM 's market capitalization equals 10,85 billion euros.

At 9.38 the stock trades 0,1 percent lower at 62,01 euros.

Historical stock prices DSM

financial analysis dsm

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.